NCT00012142View on ClinicalTrials.gov

CCI-779 in Treating Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Study Completion Date

March 31, 2004

Conditions
Prostate Cancer
Interventions
DRUG

temsirolimus

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00012142 - CCI-779 in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter